| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHST9 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | SLIRP | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
| mRNA | SH2B3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | CDRT4 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | ICE1 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | NAT16 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | MTURN | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | ADRA2A | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | NUAK1 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | PTGIR | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
